Effect of diabetes on the antinociceptive effect of β-endorphin
- 1 August 1993
- journal article
- Published by Elsevier in Brain Research
- Vol. 619 (1-2) , 76-80
- https://doi.org/10.1016/0006-8993(93)91597-l
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of δ-opioid receptorsBrain Research, 1992
- Effects of diabetes on stress-induced analgesia in miceBrain Research, 1992
- The tail-flick inhibition induced b β-endorphin administered intrathecally is mediated by activation of κ- and μ-opioid receptors in the mouseEuropean Journal of Pharmacology, 1992
- Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonistsBrain Research, 1992
- Naloxone-induced analgesia in diabetic miceEuropean Journal of Pharmacology, 1992
- Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and ?-endorphin in miceNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- β-Endorphin-(1–27) antagonizes β-endorphin- but not morphine-, D-PEN2-D-PEN2-enkephalin- and U50, 488H-induced analgesia in miceNeuropharmacology, 1988
- Release of immunoreactive met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized ratsBrain Research, 1985
- Intrathecal morphine in mice: A new techniqueEuropean Journal of Pharmacology, 1980
- C‐FRAGMENT OF LIPOTROPIN—AN ENDOGENOUS POTENT ANALGESIC PEPTIDEBritish Journal of Pharmacology, 1977